正邦科技(002157.SZ):2022年度擬向銀行等金融機構申請總額不超600億元綜合授信
格隆匯12月27日丨正邦科技(002157.SZ)公佈,公司第六屆董事會第三十四次會議決議,審議通過了《關於公司2022年度向銀行等金融機構貸款授信總量及授權的議案》,該議案尚需提交公司2022年第一次臨時股東大會審議。
根據公司2022年度的經營計劃及戰略發展規劃,為保證2022年度經營目標的順利完成,公司在2022年度擬向銀行等金融機構申請總額不超過人民幣600億元的綜合授信,公司將會嚴格控制使用授信的規模,具體借款時間、金額和用途將按照公司的實際需要進行確定。在前述綜合授信額度內,董事會提請股東大會授權公司董事會對貸款事項進行決策,並允許董事會授權公司董事長簽署借款合同及其他相關文件。前述授信額度包含子公司融資的額度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.